Amica Retiree Medical Trust Sells 2,672 Shares of Philip Morris International Inc. (NYSE:PM)

Amica Retiree Medical Trust lowered its holdings in shares of Philip Morris International Inc. (NYSE:PM) by 17.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 12,769 shares of the company’s stock after selling 2,672 shares during the period. Philip Morris International comprises about 1.5% of Amica Retiree Medical Trust’s investment portfolio, making the stock its 12th biggest position. Amica Retiree Medical Trust’s holdings in Philip Morris International were worth $1,537,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in PM. GQG Partners LLC increased its holdings in shares of Philip Morris International by 14.3% in the fourth quarter. GQG Partners LLC now owns 48,746,809 shares of the company’s stock worth $5,866,678,000 after buying an additional 6,092,558 shares during the period. Raymond James Financial Inc. purchased a new position in Philip Morris International in the 4th quarter worth approximately $522,214,000. Bank of New York Mellon Corp lifted its position in Philip Morris International by 21.0% in the fourth quarter. Bank of New York Mellon Corp now owns 16,070,482 shares of the company’s stock valued at $1,934,083,000 after purchasing an additional 2,785,987 shares during the last quarter. National Bank of Canada FI boosted its stake in shares of Philip Morris International by 161.6% during the third quarter. National Bank of Canada FI now owns 1,943,460 shares of the company’s stock valued at $235,936,000 after purchasing an additional 1,200,636 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Philip Morris International by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 139,432,392 shares of the company’s stock valued at $16,780,688,000 after purchasing an additional 1,167,810 shares during the period. Hedge funds and other institutional investors own 78.63% of the company’s stock.

Philip Morris International Price Performance

Shares of NYSE PM opened at $154.27 on Thursday. Philip Morris International Inc. has a 1 year low of $87.82 and a 1 year high of $159.51. The firm has a 50-day moving average of $144.45 and a 200 day moving average of $131.75. The stock has a market cap of $239.87 billion, a P/E ratio of 34.21, a price-to-earnings-growth ratio of 2.65 and a beta of 0.53.

Philip Morris International (NYSE:PM) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.06. Philip Morris International had a negative return on equity of 120.08% and a net margin of 7.89%. Research analysts expect that Philip Morris International Inc. will post 7.14 earnings per share for the current fiscal year.

Philip Morris International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Thursday, March 20th will be given a dividend of $1.35 per share. This represents a $5.40 annualized dividend and a yield of 3.50%. The ex-dividend date is Thursday, March 20th. Philip Morris International’s dividend payout ratio (DPR) is 119.73%.

Insider Buying and Selling at Philip Morris International

In other Philip Morris International news, Chairman Andre Calantzopoulos sold 40,643 shares of the stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $149.06, for a total transaction of $6,058,245.58. Following the sale, the chairman now directly owns 561,349 shares in the company, valued at approximately $83,674,681.94. This trade represents a 6.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Reginaldo Dobrowolski sold 5,000 shares of the business’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $149.88, for a total value of $749,400.00. Following the completion of the transaction, the vice president now owns 20,799 shares of the company’s stock, valued at $3,117,354.12. This represents a 19.38 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 131,822 shares of company stock worth $19,655,585. 0.13% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts recently commented on PM shares. UBS Group upped their price target on shares of Philip Morris International from $105.00 to $120.00 and gave the company a “sell” rating in a report on Friday, February 7th. Stifel Nicolaus raised their target price on Philip Morris International from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Barclays upped their price target on Philip Morris International from $145.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. JPMorgan Chase & Co. boosted their target price on Philip Morris International from $145.00 to $160.00 and gave the company an “overweight” rating in a research note on Tuesday, February 18th. Finally, Morgan Stanley initiated coverage on Philip Morris International in a report on Thursday, January 16th. They set an “overweight” rating and a $140.00 target price for the company. One research analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $144.56.

Philip Morris International Company Profile

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.